Literature DB >> 10074540

Human herpesvirus 8 seroprevalence and evaluation of nonsexual transmission routes by detection of DNA in clinical specimens from human immunodeficiency virus-seronegative patients from central and southern Italy, with and without Kaposi's sarcoma.

P Cattani1, M Capuano, F Cerimele, I L La Parola, R Santangelo, C Masini, D Cerimele, G Fadda.   

Abstract

In order to investigate the seroprevalence of human herpesvirus 8 (HHV-8) infection in central and southern Italy, sera from human immunodeficiency virus (HIV)-seronegative subjects, with and without Kaposi's sarcoma (KS), were analyzed by immunofluorescence assay, using BC-3, a cell line latently infected with HHV-8. High titers of antibody against HHV-8 lytic and latent antigens were detected in all 50 KS patients studied, while in 50 HIV-seronegative subjects without KS, 32 (64%) were found positive for HHV-8 antibodies. Titers in the sera of these patients were lower than those for KS patients. This data suggests that HHV-8 infection is not restricted to KS patients and that the prevalence of HHV-8 infection in the general population may be correlated with differing rates of prevalence of KS in different parts of the world. In view of these findings, possible nonsexual transmission routes were evaluated. Nested PCR was used to test for the presence of HHV-8 DNA in saliva, urine, and tonsillar swabs from KS and non-KS patients. In KS patients, 14 out of 32 tonsillar swabs (43.7%), 11 out of 24 saliva samples (45.8%), and just 2 out of 24 urine samples (8.3%) tested positive for HHV-8 DNA. In the control group, on the contrary, none of the 20 saliva and 20 urine specimens was positive for HHV-8 DNA; only 1 out of 22 tonsillar swabs gave a positive result. This data supports the hypothesis that HHV-8 infects the general population in a latent form. The reactivation of viral infection may result in salivary shedding of HHV-8, contributing to viral spread by nonsexual transmission routes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10074540      PMCID: PMC88663     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  Avoiding false positives with PCR.

Authors:  S Kwok; R Higuchi
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

2.  Classical Kaposi's sarcoma: a survey of 163 cases observed in Bari, south Italy.

Authors:  M Lospalluti; M Mastrolonardo; F Loconsole; A Conte; F Rantuccio
Journal:  Dermatology       Date:  1995       Impact factor: 5.366

3.  KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma.

Authors:  S J Gao; L Kingsley; M Li; W Zheng; C Parravicini; J Ziegler; R Newton; C R Rinaldo; A Saah; J Phair; R Detels; Y Chang; P S Moore
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

4.  Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents.

Authors:  S Mayama; L E Cuevas; J Sheldon; O H Omar; D H Smith; P Okong; B Silvel; C A Hart; T F Schulz
Journal:  Int J Cancer       Date:  1998-09-11       Impact factor: 7.396

5.  Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection.

Authors:  P S Moore; Y Chang
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

6.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

Authors:  Y Chang; E Cesarman; M S Pessin; F Lee; J Culpepper; D M Knowles; P S Moore
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

7.  Is Kaposi's-sarcoma-associated herpesvirus detectable in semen of HIV-infected homosexual men?

Authors:  J C Lin; S C Lin; E C Mar; P E Pellett; F R Stamey; J A Stewart; T J Spira
Journal:  Lancet       Date:  1995-12-16       Impact factor: 79.321

8.  Human herpesvirus 8 in Italian HIV-seronegative patients with Kaposi sarcoma.

Authors:  P Cattani; M Capuano; I Lesnoni La Parola; R Guido; R Santangelo; F Cerimele; C Masini; G Nanni; G Fadda; D Cerimele
Journal:  Arch Dermatol       Date:  1998-06

9.  A new human herpesvirus: KSHV or HHV8?

Authors:  J A Levy
Journal:  Lancet       Date:  1995-09-23       Impact factor: 79.321

10.  Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?

Authors:  V Beral; T A Peterman; R L Berkelman; H W Jaffe
Journal:  Lancet       Date:  1990-01-20       Impact factor: 79.321

View more
  17 in total

1.  Human Herpesvirus 8 Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

2.  Confirming shedding of human herpesvirus 8 in urine from infected patients in Brazil.

Authors:  Elizabeth Santos-Fortuna; Adele Caterino-de-Araujo
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

3.  Kaposi's sarcoma associated with previous human herpesvirus 8 infection in kidney transplant recipients.

Authors:  P Cattani; M Capuano; R Graffeo; R Ricci; F Cerimele; D Cerimele; G Nanni; G Fadda
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

Review 4.  Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus.

Authors:  C Boshoff; R A Weiss
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

5.  High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy.

Authors:  Craig S Miller; Joseph R Berger; Yunanan Mootoor; Sergei A Avdiushko; Hua Zhu; Richard J Kryscio
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

6.  Frequent and asymptomatic oropharyngeal shedding of human herpesvirus 8 among immunocompetent men.

Authors:  Corey Casper; Elizabeth Krantz; Stacy Selke; Steven R Kuntz; Jie Wang; Meei-Li Huang; John S Pauk; Lawrence Corey; Anna Wald
Journal:  J Infect Dis       Date:  2006-11-14       Impact factor: 5.226

Review 7.  Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.

Authors:  Lyubomir A Dourmishev; Assen L Dourmishev; Diana Palmeri; Robert A Schwartz; David M Lukac
Journal:  Microbiol Mol Biol Rev       Date:  2003-06       Impact factor: 11.056

8.  Genotypic profile of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) in urine.

Authors:  M M Beyari; T A Hodgson; W Kondowe; E M Molyneux; C M Scully; S R Porter; C G Teo
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

9.  X-box binding protein 1 contributes to induction of the Kaposi's sarcoma-associated herpesvirus lytic cycle under hypoxic conditions.

Authors:  Lucy Dalton-Griffin; Sam J Wilson; Paul Kellam
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

Review 10.  Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases.

Authors:  Dharam V Ablashi; Louise G Chatlynne; James E Whitman; Ethel Cesarman
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.